NEW PROSPECTS IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA - I-131 LIPIODOL, A PROMISING AGENT

被引：0
|
作者：
BRETAGNE, JF
RAOUL, JL
BOURGUET, P
COORNAERT, S
DUVAUFERRIER, R
DARNAULT, P
DEUGNIER, Y
HERRY, JY
GASTARD, J
机构：
[1] CHU PONTCHAILLOU,F-35033 RENNES,FRANCE
[2] ORIS IND,SACLAY,FRANCE
来源：
JOURNAL OF HEPATOLOGY | 1987年 / 4卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：P4 / P4
页数：1
相关论文
共 50 条
  • [1] NEW PROSPECTS IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA (HCC) - I-131 LIPIDOL, A PROMISING AGENT
    BOURGUET, P
    BRETAGNE, JF
    RAOUL, JL
    DUVAUFERRIER, R
    COORNAERT, S
    HERRY, JY
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 523 - 523
  • [2] THE TREATMENT OF HEPATOCELLULAR-CARCINOMA WITH I-131 LIPIODOL
    BOURGUET, P
    RAOUL, JL
    BBETAGNE, JF
    DUVAUFERRIER, R
    FAROUX, R
    COORNAERT, S
    DEUGNIER, Y
    HERRY, JY
    GASTARD, J
    JOURNAL DE MEDECINE NUCLEAIRE ET BIOPHYSIQUE, 1989, 13 (01): : 31 - 38
  • [3] Monte Carlo modeling of I-131 Lipiodol examination for the treatment of hepatocellular carcinoma
    Autret, D.
    Chiavassa, S.
    Ferrer, L.
    Laffont, S.
    Herry, J.
    Lisbona, A.
    Bardies, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S110 - S110
  • [4] CAN HEPATOCELLULAR-CARCINOMA BE TREATED WITH I-131-LABELED LIPIODOL
    BRETAGNE, JF
    RAOUL, JL
    BOURGUET, P
    COORNAERT, S
    DUVAUFERRIER, R
    DARNAULT, P
    HERRY, JY
    GASTARD, J
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1987, 11 (01): : 76 - 77
  • [5] Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma
    Lilian Schwarz
    Michael Bubenheim
    Isabelle Gardin
    Emmanuel Huet
    Ghassan Riachi
    Erick Clavier
    Odile Goria
    Pierre Vera
    Michel Scotté
    World Journal of Surgery, 2016, 40 : 1941 - 1950
  • [6] Adjuvant I-131 Lipiodol After Resection or Radiofrequency Ablation for Hepatocellular Carcinoma
    Schwarz, Lilian
    Bubenheim, Michael
    Gardin, Isabelle
    Huet, Emmanuel
    Riachi, Ghassan
    Clavier, Erick
    Goria, Odile
    Vera, Pierre
    Scotte, Michel
    WORLD JOURNAL OF SURGERY, 2016, 40 (08) : 1941 - 1950
  • [7] Adjuvant lipiodol I-131 after curative resection/ablation of hepatocellular carcinoma
    Ng, K. M.
    Niu, R.
    Yan, T. D.
    Zhao, J.
    McKay, E.
    Chu, F. C. K.
    Morris, D. L.
    HPB, 2008, 10 (06) : 388 - 395
  • [8] FEASIBILITY OF THERAPEUTIC APPLICATION OF I-131-LABELED LIPIODOL IN HEPATOCELLULAR-CARCINOMA
    PARK, CH
    SUH, JH
    YOO, HS
    LEE, JT
    KIM, DI
    CLINICAL NUCLEAR MEDICINE, 1987, 12 (02) : 157 - 157
  • [9] PREPARATION OF [I-131] LIPIODOL AS A HEPATOMA THERAPEUTIC AGENT
    LO, JG
    WANG, AY
    WEI, YY
    LUI, WY
    CHI, CW
    CHAN, WK
    APPLIED RADIATION AND ISOTOPES, 1992, 43 (12) : 1431 - 1435
  • [10] TRANSARTERIAL INTERNAL RADIATION-THERAPY WITH I-131 LIPIODOL FOR MULTIFOCAL HEPATOCELLULAR-CARCINOMA - IMMEDIATE AND LONG-TERM RESULTS
    KAJIYA, Y
    KOBAYASHI, H
    NAKAJO, M
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1993, 16 (03) : 150 - 157
12345